Bioceltix S.A. (BCX)
GPW
Closed
Aug 21, 2026
Day's Range
79.1052 wk Range
70.00Overview - BCX - Bioceltix S.A.
Key Statistics
Valuation
Enterprise Value
382.02M
P/E (Trailing)
‪-26.66‬
P/E (Forward)
‪-42.52‬
PEG Ratio
‪-0.78‬
Price / Book
‪6.54‬
EV / EBITDA
‪-23.22‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-19.45%‬
Return on Equity
‪-33.34%‬
Ownership
Shares Outstanding
5.53M
Float
4.43M
Held by Insiders
‪19.76%‬
Held by Institutions
‪22.56%‬
Price stats
Beta
‪0.91‬
50-Day Avg
‪88.29‬
200-Day Avg
‪84.77‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - BCX - Bioceltix S.A.
Peers - BCX - Bioceltix S.A.
Peer Comparison
Compared with companies in Biotechnology listed on GPW.
- BCXGPWBioceltix S.A.437.60MMarket Cap-30.35%52-week change-26.53P/E (Trailing)‪0.00%‬Profit Margin
- BSTGPWBest S.A.974.02MMarket Cap+25.15%52-week change7.34P/E (Trailing)‪23.56%‬Profit Margin
- BIOGPWBioton S.A.323.70MMarket Cap-11.14%52-week change75.40P/E (Trailing)‪1.52%‬Profit Margin
- APEGPWAps Energia S.A.156.71MMarket Cap+46.94%52-week change15.72P/E (Trailing)‪10.72%‬Profit Margin
- ASBPGPWAspire Biopharma Holdings Inc.7.83MMarket Cap-151.90%52-week change-0.01P/E (Trailing)‪-1.87%‬Profit Margin
- ASEPGPWAsep Medical Holdings Inc.1.44MMarket Cap-284.62%52-week change-0.10P/E (Trailing)‪-538.03%‬Profit Margin
Profile Summary - BCX - Bioceltix S.A.
About
Bioceltix S.A. is a biotechnology company focused on developing and commercializing innovative veterinary biomedicines. Its primary function is to enhance animal health through products designed for companion animals and livestock. Leveraging advancements in cell therapy and biologics, Bioceltix aims to address unmet…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
